Creso Pharma Share Price and Company Fundamentals



Price
$0.117
Change
0.007 (6.364%)
52 week
0.024 - 0.47

Last traded: Today at 3:33 AM

Creso Pharma Limited develops, registers, and commercializes pharmaceutical-grade cannabis, and hemp-based nutraceutical products and treatments for human and animal health in Europe, the Middle East, North America, and the Asia Pacific. The company develops and commercializes therapeutic products; and cultivates and harvests cannabis plants, as well as supplies dried cannabis plant retail products. Its products include anibidiol, a complementary feed product for companion animals; cannaQIX, a nutraceutical product containing hemp oil extract, and vitamins and zinc that reduces stress and supports psychological and nervous functions in humans; and topical and skin care products, which include cannaDOL, a CBD-based topical gel associated with a mixture of cooling and warming essential oils. The company also offers nutraceutical products, such as cannaQIX, a hemp oil-derived food supplement under the Cannamics brand. Creso Pharma Limited was incorporated in 2015 and is headquartered in Nedlands, Australia.

Key Metrics

PE ratio

-

PB ratio

7.80

Dividend yield

Beta

3.36

Market cap

$140M

Enterprise value

$102.1M

Company profile

Primary activitiesDeveloping, registering and commercialising pharmaceutical-grade cannabis and hemp-based products for use across a broad spectrum of consumer,. Industry and research applications.
Industry / SectorDrug Manufacturers—Specialty & Generic / Healthcare
Websitehttp://www.cresopharma.com
Mailing address145 Stirling Highway Suite 5 CPC 300 Barangaroo Avenue Barangaroo Nedlands WA 6009 Australia
Phone / Fax61 8 9389 3100 / 61 8 9389 3199
Share registryAUTOMIC REGISTRY SERVICES

Dividends

Creso Pharma does not pay dividends.

Company Executives

As of Aug 2021, following are the company executives and directors listed on Creso Pharma.

NameTitleAgeTotal Pay
Mr. Adam Blumenthal B.Com., M.B.A.Co-Founder & Non-Exec. Chairman269k
Mr. Boaz Wachtel M.A., M.D., MBACo-Founder & Non-Exec. Director6077.5k
Mr. Christopher GrundyChief Financial Officer341.35k
Dr. James Anthony Ellingford M.B.A., Ph.D., PG(Corp Mgmt), D.Mgt, MBA, AICDExec. Director184.4k
Dr. Gian TreppCommercial & Marketing Director
Ms. Erlyn Saromines Dale A.C.I.S., B.Com., BCom., GradDipACG, AGIA, ACISJoint Company Sec.
Mr. Winton William Willesee BBus, BBus., CPA, DipEd, DipEd., PGDipBus, PGDiJoint Company Sec.
Dr. Simon H. W. BuckinghamConsultant58

Profitability and management effectiveness

Profit margin

0.00%

Operating margin

-574.43%

Return on assets

-42.06%

Return on equity

-201.50%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Creso Pharma is 140M and its enterprise value is 102.1M. The enterprise value to revenue ratio of CPH is 41.71.

The CPH's stocks Beta value is 3.36 making it 236% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Creso Pharma (CPH)

Creso Pharma (ASX:CPH) Frequently Asked Questions

1. What is Creso Pharma's Stock Symbol?

Creso Pharma trades on ASX under the ticker symbol "CPH".

2. What is Creso Pharma's stock price today?

One share of CPH stock can currently be purchased for approximately $0.117.

3. How can I contact Creso Pharma?

Creso Pharma's mailing address is 145 Stirling Highway Suite 5 CPC 300 Barangaroo Avenue Barangaroo Nedlands WA 6009 Australia. The company can be reached via phone at 61 8 9389 3100.

4. What is Creso Pharma's official website?

The official website of Creso Pharma is http://www.cresopharma.com.

5. Which share registry manages Creso Pharma's stock?

Creso Pharma's stock is managed by AUTOMIC REGISTRY SERVICES.